At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Jun 26, 2026 at 16:20 ET
PDS Biotechnology Corp filed a DEFA14A, which is additional definitive proxy soliciting material. The document body is almost entirely comprised of encoded/compressed graphical data and contains no readable text describing specific proposals, shareholder votes, or activist demands. With no substantive content available, the filing appears to be a routine cover-page-only submission of graphic exhibits related to a proxy solicitation.
- Filed as DEFA14A (additional definitive proxy soliciting materials) on 2026-06-26
- Filer is PDS Biotechnology Corp, a pharmaceutical preparations company
- Document text contains only EDGAR headers, a Schedule 14A cover page, and two large binary graphic files (JPG images)
- No textual details on meeting agenda, proposals, or activist demands were found in the filing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access